Диссертация (1141195), страница 20
Текст из файла (страница 20)
Haenisch S, Zimmermann U, Dazert E, Wruck CJ, Dazert P, Siegmund W,Kroemer HK, Warzok RW, Cascorbi I. Influence of polymorphisms of ABCB1 andABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.Pharmacogenomics J. 2007 Feb;7(1):56-65. Epub 2006 Jun 20.152. Han H, Long H, Wang H, Wang J, Zhang Y, Wang Z. Progressive apoptoticcell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a novelpattern of apoptosis and the mechanisms. Am J Physiol Heart Circ Physiol. 2004Jun;286(6):H2169-82. Epub 2004 Jan 22.153.
Han JY, Lim HS, Yoo YK, Shin ES, Park YH, Lee SY, Lee JE, Lee DH, KimHT, Lee JS. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms withirinotecan-pharmacokinetics and clinical outcome in patients with advanced nonsmall cell lung cancer. Cancer. 2007 Jul 1;110(1):138-47154. Han Li, Zhang Yan, Wang Ning, Guo Xiao-Juan, Zang Cai-Hong, Jiang JinHua, Ma Fang, and Wang Qing-Duan. Using Rhodamine 123 Accumulation in CD8+Cells as a Surrogate Indicator to Study the P- Glycoprotein Modulating Effect ofCepharanthine Hydrochloride In Vivo. J Biomed Biotechnol. 2011; 2011: 281651142155. Harjai K.J.
Potential new cardiovascular risk factors: left ventricularhypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, andfibrinogen. Ann Intern Med 1999;131:376—86)156. Hartmann G, Kim H, Piquette-Miller M.Regulation of the hepatic multidrugresistance gene expression by endotoxin and inflammatory cytokines inmice.IntImmunopharmacol. 2001 Feb;1(2):189-99.157. Hitzl M, Drescher S, van der Kuip H, Schäffeler E, Fischer J, Schwab M,Eichelbaum M, Fromm MF. The C3435T mutation in the human MDR1 gene isassociated with altered efflux of the P-glycoprotein substrate rhodamine 123 fromCD56+ natural killer cells. Pharmacogenetics.
2001 Jun;11(4):293-8.158. Hitzl M, Schaeffeler E, Hocher B, Slowinski T, Halle H, Eichelbaum M,Kaufmann P, Fritz P, Fromm MF, Schwab M. Variable expression of P- glycoproteinin the human placenta and its association with mutations of the multidrug resistance1 gene (MDR1, ABCB1). Pharmacogenetics. 2004 May;14(5):309-18.159. HodgesLM,AltmanRB.VeryMarkovaSM,importantChinnLW,pharmacogeneGowJM,summary:KroetzDL,ABCB1KleinTE,(MDR1,P-glycoprotein).Pharmacogenet Genomics. 2011 Mar;21(3):152-61.160. Hodgson D.R.
Wellings R. Harbron C. Practical perspectives of personalizedhealthecare in oncology. N.Biotechnol 2012: Mar 15.(Epub ahead of print)161. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, JohneA,CascorbiI,GerloffT,RootsI,EichelbaumM,BrinkmannU.Functionalpolymorphisms of the human multidrug-resistance gene: multiplesequence variations and correlation of one allele with P-glycoprotein expression andactivity in vivo.
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3473-8.162. Huang JS, Zhang XJ, Xu X, Guan M, Zhou YL, Lü L, Zou HJ. [Influence ofMDR1 gene C3435T on peripheral white blood cell counts in workers exposed to143benzene]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2011 Jan;29(1):203.163. Huls M, Kramers C, Levtchenko EN, et al. P-glycoprotein-deficient micehave proximal tubule dysfunction but protected against ischemic renal injury.
KidneyInt. 2007;72:1233-41.164. Huls M, Russel FG, Masereeuw R. The role of ATP binding cassettetransporters in tissue defense and organ regeneration. J Pharmacol Exp Ther. 2009Jan;328(1):3-9. Epub 2008 Sep 12165. Ito K, Nguyen HT, Kato Y, Wakayama T, Kubo Y, Iseki S, Tsuji A.Pglycoprotein (Abcb1) is involved in absorptive drug transport in skin. J ControlRelease. 2008 Nov 12;131(3):198-204. Epub 2008 Aug 12166. Jeannesson E, Siest G, Bastien B, Albertini L, Aslanidis C, Schmitz G,Visvikis-Siest S.Clin Chim Acta.
Association of ABCB1 gene polymorphisms withplasma lipid and apolipoprotein concentrations in the STANISLAS cohort. 2009May;403(1-2):198-202. Epub 2009 Mar 11167. Jessica L. Mega, MD, MPH, Sandra L. Close, PhD, Stephen D. Wiviott, MD,Lei Shen, PhD, Joseph R. Walker, PharmD, Tabassome Simone, MD, PhD, Elliott M.Antman, MD, Eugene Braunwald, MD, and Marc S.
Sabatine, MD, MPH GeneticVariants in ABCB1, CYP2C19, and Cardiovascular Outcomes Following Treatmentwith Clopidogrel and Prasugrel.Lancet. 2010 October 16; 376(9749): 1312–1319168. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability inChinese hamster ovary cell mutants. Biochim Biophys Acta.
1976 Nov11;455(1):152-62. 169. Kamau SW, Krämer SD, Günthert M, Wunderli-Allenspach H. Effect of themodulation of the membrane lipid composition on the localization and function of Pglycoprotein in MDR1-MDCK cells. In Vitro Cell Dev Biol Anim. 2005 JulAug;41(7):207-16.144170. Kanagasabai R, Krishnamurthy K, Druhan LJ, Ilangovan GJ BiolChem.Forced expression of heat shock protein 27 (Hsp27) reverses P- glycoprotein(ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistanthuman breast cancer cells.2011 Sep 23;286(38):33289- 300. Epub 2011 Jul 22. 171. Kanemura Y.
Development of cell-processing systems for human stem cells(neural stem cells, mesenchymal stem cells, and iPS cells) for regenerative medicine.Keio J Med. 2010;59(2):35-45. ]172. Kannan P, John C, Zoghbi SS, Halldin С, Gottesman MM, Innis RB, andHallImagingMDtheFunctionofP-GlycoproteinWithRadiotracers:Pharmacokinetics and In VivoApplicationsClinPharmacolTher. 2009 October; 86(4):368–377.173. Karssen AM, Meijer OC, van der Sandt IC, de Lange EC, de Boer AG, deCloet ER. Multidrug resistance P-glycoprotein hampers the access of cortisol but notof corticosterone to mouse and human brain.
Endocrinology. 2001 June; 142(6):268694.174. Kim KA, et al. Effect of CYP3A5*3 genotype on the pharmacokinetics andpharmacodynamics of amlodipine in healthy Korean subjects. Clin PharmacolTher. 2006;80:646–656.175. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, TaylorA, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR.Identification of functionally variant MDR1 alleles among European Americans andAfrican Americans. Clin Pharmacol Ther.
2001;70:189–99.176. Kimchi-Sarfaty C., Oh J.M., Kim I.W., Sauna Z.E., Calcagno A.M.,Ambudkar S.V., Gottesman M.M. A "silent" polymorphism in the MDR1 genechanges substrate specificity.// Science. 2007. Vol. 315(5811). P. 525-528.145177. Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesteroltransporters: function and regulation.
Pharmacol Rev. 2010 Mar;62(1):1-96. Epub2010 Jan 26.178. Knaapen MW, Davies MJ, De Bie M, Haven AJ, Martinet W, Kockx MM.Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res. 2001 Aug1;51(2):304-12179. Kooij G, Backer R, Koning JJ, Reijerkerk A, van Horssen J, van der Pol SM,Drexhage J, Schinkel A, Dijkstra CD, den Haan JM, Geijtenbeek TB, de Vries HE.P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One.2009 Dec 8;4(12):e8212.180.
Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I,Cascorbi I, Walker LC, Kroemer HK, Warzok RW, Vogelgesang S.MDR1-PGlycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides-implications for the mechanisms of Abeta clearance at the blood- brainbarrier.BrainPathol. 2007 Oct;17(4):347-53. 181. Kurata Y, Ieiri I, Kimura M, Morita T, Irie S, Urae A, Ohdo S, Ohtani H,Sawada Y, Higuchi S, Otsubo K. Role of human MDR1 gene polymorphism inbioavailability and interaction of digoxin, a substrate of P-glycoprotein.
ClinPharmacol Ther. 2002 Aug;72(2):209-19.182. Kurose K, Saeki M, Tohkin M, Hasegawa R. Thyroid hormone receptormediates human MDR1 gene expression-Identification of the response regionessential for gene expression.ArchBiochemBiophys. 2008 Jun 1;474(1):82-90. Epub2008 Mar 25183. Kurzawski M, Bartnicka L, Florczak M, Górnik W, Droździk M. ImpactofABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxinserum concentration in congestive heart failure patients. Pharmacol Rep.
2007 JanFeb;59(1):107-11146184. Kuzuya T., Kobayashi T., Moriyama N.,Nagasaka T., Yokoyama I., UchidaK., NakaoA., Nabeshima T. Amlodipine, but not MDR1 polymorphisms, alters thepharmacokineticsofcyclosporineAinJapanesekidneytransplantrecipients//Transplantation. 2003. Vol.76, №5. P. 865–868185. Lacchini R, Fiqueiredo VN, Demacq C, Coeli-Lacchini FB, Martins LC,Yuqar-Toledo J, Coca A, Tanus-Santos JE, Moreno H Jr. MDR-1 C3435Tpolymorphism may affect blood pressure in resistant hypertensive patientsindependently of its effects on aldosterone release. J Renin Angiotensin AldosteroneSyst.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
